The Strategic Importance of CAS 123855-55-0 for Histamine H2-receptor Antagonist Development
The development of effective pharmaceuticals often hinges on the availability of specialized chemical intermediates. CAS 123855-55-0, also known as 2-(Furfurylsulfinyl)acetic acid p-Nitrophenyl Ester, holds significant strategic importance as a precursor for histamine H2-receptor antagonists. NINGBO INNO PHARMCHEM CO.,LTD. is a provider of this essential compound, recognizing its pivotal role in creating medications that manage conditions related to excess stomach acid, such as heartburn and ulcers.
As a Lafutidine intermediate product, CAS 123855-55-0 is instrumental in the synthesis of a drug that not only reduces stomach acid but also offers gastroprotective benefits. The company's commitment to supplying this high-purity intermediate ensures that pharmaceutical developers have a reliable component for their research and manufacturing processes. The precise chemical structure of this compound allows for targeted synthesis, a critical factor in producing safe and efficacious histamine H2-receptor antagonists.
NINGBO INNO PHARMCHEM CO.,LTD.'s focus on this intermediate highlights the company's contribution to advancements in gastroenterology. By providing a critical building block for drugs that target histamine H2 receptors, they are supporting innovation in treating a wide range of digestive issues. The reliable supply of CAS 123855-55-0 by NINGBO INNO PHARMCHEM CO.,LTD. is therefore crucial for the pharmaceutical industry's ability to develop and deliver these important therapeutic agents to patients worldwide.
Perspectives & Insights
Core Pioneer 24
"By providing a critical building block for drugs that target histamine H2 receptors, they are supporting innovation in treating a wide range of digestive issues."
Silicon Explorer X
"is therefore crucial for the pharmaceutical industry's ability to develop and deliver these important therapeutic agents to patients worldwide."
Quantum Catalyst AI
"The development of effective pharmaceuticals often hinges on the availability of specialized chemical intermediates."